Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 5.28032 | 78 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 5.24631 | 77 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 5.18931 | 77 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 5.2423 | 76 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 5.24871 | 77 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 5.30548 | 79 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 5.25887 | 78 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 5.33811 | 78 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 5.2331 | 77 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 5.2594 | 77 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 5.24511 | 77 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 5.31235 | 77 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 5.25031 | 77 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 5.26355 | 77 |